You are here

Hong Kong

Zephyrm rides IPO updraft toward Hong Kong listing, seeking cash for phase 3 cell therapy trials

Fierce Biotech

Wed, 10/2/24 - 10:40 am

Zephyrm Bioscience

graft vs host disease

Duality plans Hong Kong IPO to fund trials of BioNTech-partnered ADCs and beyond

Fierce Biotech

Tue, 08/27/24 - 11:34 am

Chinese biotech firm HighTide Therapeutics slashes Hong Kong IPO size by 80% to US$35.6 million

Yahoo/South China Morning Post

Thu, 12/14/23 - 09:44 am

HighTide Therapeutics

WuXi Biologics' medical research unit eyes up to $471 million in Hong Kong IPO

Reuters

Mon, 11/6/23 - 07:15 pm

Boehringer Ingelheim to incubate biotechs with Hong Kong R&D leader

Endpoints

Fri, 06/17/22 - 09:51 am

Boehringer Ingelheim

AstraZeneca partners to set up Hong Kong biotech incubator

Fierce Biotech

Wed, 02/10/21 - 10:21 am

AbbVie's Covid-19 antibody partner wraps $221M Hong Kong IPO

Endpoints

Thu, 12/17/20 - 11:05 am

RemeGen grabs one of the world's largest ever biotech IPOs

Fierce Biotech

Mon, 11/9/20 - 11:10 am

JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China

Endpoints

Wed, 11/4/20 - 10:30 am

JW Therapeutics

Juno Therapeutics

RemeGen readies $514M IPO as HKEX adds jewel to the crown

Endpoints

Wed, 10/28/20 - 10:43 am

How hot is Hong Kong's biotech IPO market? Two biotechs just raised $800M total

Endpoints

Thu, 10/8/20 - 11:14 pm

Everest Medicines

Genor Biopharma

Ex-Celgene exec steers his biotech startup to Hong Kong IPO as potential cancer drug launch looms

Endpoints

Thu, 08/27/20 - 10:42 am

Juno joint venture seeks IPO haul to bring CAR-Ts to China

Fierce Biotech

Mon, 08/17/20 - 10:33 am

JW Therapeutics

Juno Therapeutics

China's CRO powerhouse Tigermed to seek $1B IPO in Hong Kong — report

Endpoints

Mon, 07/20/20 - 10:22 am

Hangzhou Tigermed

Ophthalmic drugs, cancer cell therapies attract $340M+ on two HKEX biotech debuts

Endpoints

Fri, 07/10/20 - 10:52 am

Ocumension Therapeutics

Immunotech Biopharm

Pandemic fears force Chinese biotech to postpone Hong Kong IPO meetings — Bloomberg

Endpoints

Mon, 02/3/20 - 10:30 am

Wuhan Coronavirus

InnoCare Pharma

Tasly Biopharma pitches long-awaited IPO — will it trigger another $1B gold rush on HKEX?

Endpoints

Tue, 06/25/19 - 11:28 pm

Tasly Biopharma

This Chinese pharma filed for an IPO last September. Seven months and a $283M investment later, they are back at the HKEX

Endpoints

Fri, 04/12/19 - 11:44 pm

Hansoh Pharmaceutical

Chinese Immuno-Oncology Company to Raise $282 Million Via Hong Kong IPO

CP Wire

Mon, 02/18/19 - 11:21 am

CStone Pharmaceuticals

immuno-oncology

WuXi AppTec prices Hong Kong offering in stormy market

BioCentury

Sat, 12/8/18 - 10:27 am

Pages